Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Fibrosis, characterized by excessive extracellular matrix accumulation, is a common feature of many connective tissue diseases, notably scleroderma (systemic sclerosis). Experimental studies suggest that a complex network of intercellular interactions involving endothelial cells, epithelial cells, fibroblasts and immune cells, using an array of molecular mediators, drives the pathogenic events that lead to fibrosis. Transforming growth factor-beta and endothelin-1, which are part of a cytokine hierarchy with connective tissue growth factor, are key mediators of fibrogenesis and are primarily responsible for the differentiation of fibroblasts toward a myofibroblast phenotype. The tight skin mouse (Tsk-1) model of cutaneous fibrosis suggests that numerous other genes may also be important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been shown that persistent inflammation results in up-regulation of various proinflammatory cytokines and chemokines, which further induce the expression of growth factors (e.g., PDGF, TGF-β1, activin), stimulating fibroblast proliferation, their differentiation into myofibroblasts, and production of ECM in a variety of fibrotic diseases, including hypertrophic scars and keloids [259–261].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [259]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 1×
“These cells, which are characterized by the presence of stress fibres containing αsmooth muscle actin (SMA), play a pivotal role in ECM deposition and wound contraction during the normal wound healing process [26].”
BackgroundRegulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629 · cited 1×
“Importantly, it also acts as a switch, turning on the production of other growth factors such as vascular endothelial growth factor, which then signal to endothelial cells [28,29].”
BackgroundThe endothelin system in pulmonary arterial hypertension
GALIE, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 515 · cited 2×
“Cardiovascular Research © Elsevier 2004 [4].”
BackgroundConnective Tissue Growth Factor: What's in a Name?
Moussad, E. E.-D. A., & Brigstock, D. R. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3059 · Cited by 470 · cited 1×
“CTGF, a cytokine that stimulates fibroblast growth and upregulation of collagen and fibronectin in vitro [11], is a difficult molecule to study experimentally, but there is evidence to suggest it mediates certain effects of TGF-β and ET-1 on ECM production [12,13].”
BackgroundHocher, B., Thöne-Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V, Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H. H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 409 · cited 2×
“In this model, pronounced renal fibrosis was associated with an age-dependent decrease in glomerular filtration that culminated in fatal kidney disease [ 15 ].”
BackgroundDistler, J. H. W., Jüngel, A., Huber, L. C., Schulze‐Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gay, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22314 · Cited by 383 · cited 1×
“For example, using this model, the protein kinase inhibitor imatinib mesylate (a selective, dual inhibitor of TGF-β and platelet-derived growth factor) was shown to have potent antifibrotic effects [22], although perhaps not in later stages of fibrosis [23].”
MethodA tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation.
Siracusa, L. D., McGrath, R., Ma, Q., Moskow, J. J., Manne, J., Christner, P. J., Buchberg, A. M., & Jimenez, S. A. (1996) · Genome Research · doi:10.1101/gr.6.4.300 · Cited by 293 · cited 1×
“and the major component of microfibrils, found with or without associated elastin [17].”
BackgroundPulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Hocher, B., Schwarz, A., Fagan, K. A., Thöne-Reineke, C., El-Hag, K., Kusserow, H., Elitok, S., Bauer, C., Neumayer, H.-H., Rodman, D. M., et al. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.1.4030 · Cited by 219 · cited 1×
“Other work in a transgenic mouse model has shown ET-1 over-expression to lead to the recruitment of inflammatory cells in respiratory tissues and subsequent development of progressive pulmonary fibrosis [16].”
BackgroundParacrine regulation of keratinocyte proliferation and differentiation
Werner, S., & Smola, H. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01955-9 · Cited by 184 · cited 1×
“Importantly, it also acts as a switch, turning on the production of other growth factors such as vascular endothelial growth factor, which then signal to endothelial cells [28,29].”
BackgroundMechanisms and consequences of fibrosis in systemic sclerosis
Denton, C. P., Black, C. M., & Abraham, D. J. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0115 · Cited by 181 · cited 1×
“also internal organs such as lungs and kidneys, leading to organ dysfunction and failure [1].”
BackgroundSelf-citation
Cited by
Items 101–151 of 151
Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies
Peiró, T., Alonso‐Carpio, M., Ribera, P., Almudéver, P., Roger, I., Montero, P., Marín, S., Milara, J., & Cortijo, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315319 · Cited by 12
“Epithelial–mesenchymal cross-talk has also been described between keratinocytes and dermal fibroblasts [50], and a distinctive feature of this process is the alteration in cell surface markers from an epithelial phenotype to an upregulation of mesenchymal markers.”
BackgroundCCN2: a bona fide target for anti-fibrotic drug intervention
Leask, A. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0125-3 · Cited by 11
“A possible rationale for why no therapy has been successful is that prior approaches have targeted individual cytokines; it is likely that proteins such as transforming growth factor β, endothelin-1, angiotensin, and platelet-derived growth factor synergize to produce fibrosis in vivo ( Krieg et al.2007; Leask 2010b).”
BackgroundWilczyñski, J. M. O., Mena, H. A., Ledesma, M. M., Olexen, C. M., Podaza, E., Schattner, M. A., Negrotto, S., Errasti, A. E., & Silva, E. A. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162671 · Cited by 12
Talebloo, N., Ochoa-Bernal, M. A., Kenyon, E., Mallett, C. L., Fazleabas, A. T., & Moore, A. V. (2023) · Molecular Imaging and Biology · doi:10.1007/s11307-023-01833-6 · Cited by 11
“Fibrosis is defined by the overexpression of collagen and is considered as one of the hallmarks of the disease [58, 59].”
BackgroundZhang, H., Gao, X., Gui, Z., Suo, C., Tao, J., Han, Z., Ju, X., Tan, R., Gu, M., & Wang, Z. (2023) · Translational Andrology and Urology · doi:10.21037/tau-22-506 · Cited by 9
Liu, W., Jiao, Y., Tian, C. L., Hasty, K. A., Song, L., Kelly, D. M., Li, J., Chen, H., Gu, W., & Liu, S. (2020) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-020-00592-4 · Cited by 9
The dual distinct role of telomerase in repression of senescence and myofibroblast differentiation
Harada, M., Hu, B., Lu, J., Wang, J., Rinke, A. E., Wu, Z. B., Liu, T., & Phan, S. H. (2021) · Aging · doi:10.18632/aging.203246 · Cited by 10
Kweon, B., Kim, D.-U., Oh, J.-Y., Oh, H., Kim, Y., Mun, Y., Bae, G., & Park, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.941955 · Cited by 10
“α-SMA is then expressed in the fibrotic tissue area replacing the normal parenchymal tissue in which PSC is activated, and the synthesis of ECM factors, including diverse types of collagen and fibronectin, increases in this area (Schneider et al., 2001; Krieg et al., 2007; Apte et al., 2011).”
BackgroundSerum osteopontin and vitronectin levels in systemic sclerosis
Gündoğdu, B., Yolbaş, S., Yılmaz, M., Aydın, S., & Koca, S. S. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/68627 · Cited by 9
Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis
Jiménez, S. A., & Piera-Velázquez, S. (2023) · Current Rheumatology Reviews · doi:10.2174/0115733971261932231025045400 · Cited by 7
Characteristics of NK cell activity in patients with systemic sclerosis
Salim, P. H., Jobim, M., Bredemeier, M., Chies, J. A. B., Brenol, J. C. T., Jobim, L. F. J., & Xavier, R. M. (2013) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/s2255-5021(13)70007-5 · Cited by 7
Tyrosine kinase inhibitor therapy for systemic sclerosis: Quo Vadis?
Mendoza, F. A., & Jiménez, S. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30545 · Cited by 9
Serum prolidase activity in systemic sclerosis
Çelik, A., Birer, M. N., & Kılınç, M. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3677-7 · Cited by 8
Wang, L., Yu, F., Sun, H., & Lu, L. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.11.067 · Cited by 7
Can, G., Sarıoğlu, S., Bırlık, M., Kenar, G., Soysal, Ö., Solmaz, D., Gerdan, V., Önen, F., Akkoç, N., & Akar, S. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2012-25 · Cited by 8
“4 studies indicate that myofibroblasts may play a central role in the development of fibrosis by expressing α-SMA in patients with SSc [7].”
BackgroundLi, Y., Kilani, R. T., Hartwell, R., & Ghahary, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22739 · Cited by 7
“Silicacontainingmacrophages, fibroblasts, and lymphocytes are often restricted to the periphery of nodules (Krieg et al., 2007).”
BackgroundThe Immunopathogenesis and Immunopathology of Systemic Lupus Erythematosus
Pisetsky, D. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1189-5_2 · Cited by 6
Role of Growth Factors in the Pathogenesis of Systemic-Sclerosis-Associated Fibrosis
Mendoza, F. A., Piera-Velázquez, S., & Jiménez, S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199596 · Cited by 5
Evaluation of transforming growth factor beta 1 in dogs with osteoarthritis
Neumann, S., & Lauenstein-Bosse, S. (2018) · Open Veterinary Journal · doi:10.4314/ovj.v8i4.6 · Cited by 7
“This goes along with proliferation and activation of fibroblasts that synthesise high amounts of altered extracellular matrix (Krieg et al., 2007).”
BackgroundOral Sub Mucous Fibrosis: Exploring Therapeutic Strategies Using -anti TGF β Drugs
Sheshaprasad, R., & Pai, A. (2018) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2018.3.2.21 · Cited by 8
Giovanini, A. F., Leonardi, D. P., Baratto‐Filho, F., Valença, P. C., Moresca, R. C., Moro, A., & Schramm, C. A. (2011) · Brazilian Dental Journal · doi:10.1590/s0103-64402011000500004 · Cited by 4
“(13), who analyzed biopsies of fibroproliferative tissue and found a significant increase in the number of myofibroblasts, particularly in the deep derms when compared with usual connective tissue.”
BackgroundGözel, N., DURAN, F., YILDIRIM, A., Yolbaş, S., ÖNALAN, E., ÖZERCAN, İ. H., & Koca, S. S. (2018) · Archives of Rheumatology · doi:10.5606/archrheumatol.2018.6648 · Cited by 5
Xiao, Y., Hong, X., Zhi, L., Li, Y.-N., Regensburger, M., Marxreiter, F., Görg, B., Koziel, S., Györfi, A., Filla, T., et al. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.02.021 · Cited by 3
Sun, Z., Qin, Y., & Zhang, X. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1490745 · Cited by 4
Roles of heat shock factor 1 in isoproterenol-induced myocardial fibrosis in mice
Xie, Y., Zhang, L., Zhang, B., & Li, F. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4157 · Cited by 3
Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma
Orhan, S. O., Tektemur, A., Gözel, N., Özercan, İ. H., Yolbaş, S., Yıldırım, A., Etem, E. Ö., & Koca, S. S. (2018) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1707-88 · Cited by 3
“Myofibroblasts also produce profibrotic cytokines (interleukin [IL]-6) and growth factors (TGF-β1, connective tissue growth factor, and platelet-derived growth factor) (3,4).”
BackgroundQadri, M. M. (2020) · Chapman University Digital Commons (Chapman University) · doi:10.36837/chapman.000208 · Cited by 2
Dextrose Prolotherapy - Mechanism of Action
Wilson, M., Topping, A., & Praet, S. (2022) · Acta Scientific Orthopaedics · doi:10.31080/asor.2022.05.0585 · Cited by 1
Hou, T., Zhang, L., Zhao, L., Gao, F., & Xing, T. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105576 · Cited by 2
“Fibroblasts and myofibroblasts serve as primary stromal cells responsible for producing ECM components, which are essential for the functional assembly of fibrous ECM structures (Chapman et al., 2016; Krieg et al., 2007).”
Wang, S., Yang, J., Macarak, E. J., Wermuth, P. J., Rosenbloom, J., & Uitto, J. (2020) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000080 · Cited by 1
“Indeed, persistent production of ECM macromolecules by activated mesenchymal cells, often with characteristics of myofibroblasts, differentiates controlled repair taking place during normal wound healing from tissue fibrosis, the hallmark of fibrotic diseases.(10-13) The chronic nature of the fibrotic processes and th…”
BackgroundBlood Platelets and Systemic Sclerosis
Lepreux, S., Solanilla, A., Villeneuve, J., Constans, J., Desmoulière, A., & Ripoche, J. (2012) · InTech eBooks · doi:10.5772/25866
“Fibroblasts produce keratinocyte growth factor and, conversely, keratinocytes signal to fibroblasts leading to their activation, production of a variety of cytokines/chemokines/angiogenic mediators, induction of ECM component synthesis and -SMA expression [102, 103].”
BackgroundArbeláez, A. M., Bastidas, A., Quintana, G., Valle‐Oñate, R., Reyes, E., Bello, J., Jaimes, D. A., & Avila, M. (2008) · Revista Colombiana de Reumatología
TAK1 Mediates TGF beta-1 Responses in Gingival Fibroblasts
Kuk, H. (2014) · Scholarship@Western (Western University)
Características de atividade das células natural killer em pacientes com esclerose sistêmica
Salim, P. H., Jobim, M., Bredemeier, M., Chies, J. A. B., Brenol, J. C. T., Jobim, L. F. J., & Xavier, R. M. (2013) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042013000100007
Systemic sclerosis and related connective tissue diseases: present and future
Rubin, L. J., Black, C. M., Denton, C. P., & Seibold, J. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2185
“Krieg, Abraham, and Lafyatis [3] review a series of experimental studies that suggest that a complex network of intercellular interactions involving”
BackgroundSuppressing the Skin Immune System
Nasir, A., & Gaspari, A. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5034-4_17
Garcia, A. G. W., Scariot, R., de Araújo, M. R., Cunha, E. J., Henn, J. M., Grossi, J. R. A., Deliberador, T. M., Zielak, J. C., & Giovanini, A. F. (2014) · Redalyc (Universidad Autónoma del Estado de México)
da Silva, V. M. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-14122015-145516
Pathogenesis and Treatment of Keloids
Tosa, M., & Ogawa, R. (2020) · Nihon Ika Daigaku Igakkai Zasshi · doi:10.1272/manms.16.8
Urban, H. (2020) · The Sydney eScholarship Repository (The University of Sydney)
WNT5A induziert über eine JNK-abhängige Aktivierung von latentem TGF-β Fibrose
Chen, C. (2017) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
(2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328317a234
Pihlajaniemi, T. A., & Heljäsvaara, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726121845.793560503
Karatepe, B. A., Yolbaş, S., Yıldırım, A., Hoşgün, D., Özercan, İ. H., Etem, E. Ö., & Koca, S. S. (2024) · Journal of Medical Topics and Updates · doi:10.58651/jomtu.1404234
Georgiou, G., Minadakis, G., Karathanasis, N., Savva, K., Athieniti, E., Bourdakou, M. M., & Spyrou, G. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.04.621824
Fibulin-5 promotes fibroblast activation through LTBP-4 to improve the pathogenesis of hemorrhoids
Zhao, Y., Xiao, K., Wu, Y., Li, D., Xie, R., Liao, M., & Sun, F. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04540-4 · Cited by 1
“Pathological displacement of anal cushions and venous dilation reflect inadequate fibroblast activation, compromising tissue integrity in hemorrhoidal disease [9, 10].”
Pérez-Miles, F., Gabriel, R., Miglio, L., Bonaldo, A., Gallon, R., Jiménez, J. J., & Bertani, R. (2008) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.184594
Oh, J. M., Hahn, H. M., Suh, Y. C., Hong, K. Y., Kim, B. J., Jin, U. S., & Lee, D. B. (2026) · Aesthetic Surgery Journal · doi:10.1093/asj/sjag018
Les lymphocytes T folliculaires auxiliaires dans la sclérodermie systémique
Ricard, L. (2019) · theses.fr (ABES) · doi:10.70675/bef55222zfe07z4dddz9452z5d593b588ba1
Cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosis
Dapas, M., Clevenger, M. H., Makinde, H. M., Therron, T., Carlson, D. A., Carns, M. A., Aren, K., Wei, C., Mian, K., Muhammad, L. N., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.195322 · Cited by 2
“When damaged, epithelial cells release signals that help induce fibroblast activation to promote wound healing (41).”
Metadata
- Authors
- Krieg, T., Abraham, D., & Lafyatis, R.
- Affiliations
- University of Cologne (DE)
- The Royal Free Hospital (GB)
- Boston University (US)
- Corresponding author
- Krieg, Thomas
- Venue
- Arthritis Research & Therapy
- Published
- 2007
- Volume
- 9
- Issue
- Suppl 2
- Pages
- S4
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC2072888
- OpenAlex
- W2145999911
- Cited by
- 151
- References
- 35
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 5 · 2018: 11 · 2017: 10 · 2016: 13 · 2015: 8 · 2014: 5 · 2013: 10 · 2012: 12
- Type
- conference abstract
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Arthritis Research & Therapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- OpenBU (Boston University) (submittedVersion)
- Funders
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- fibrosis, connective tissue diseases, systemic sclerosis, myofibroblasts, extracellular matrix accumulation, TGF-beta, endothelin-1, connective tissue growth factor, fibroblast differentiation, tight-skin mouse, skin fibrosis, endothelial cells, immune cells
- MeSH terms
- Animals, Cell Communication, Connective Tissue Diseases, Epithelial Cells, Fibroblasts, Fibrosis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.